We sought to define the role of hypoxemia in eliciting the cardiovascular responses to apnea during exercise. Eleven men performed repeated apneas during 100W steady-state exercise, either with normoxic gas (air) or 95% oxygen (oxygen). Beat-by-beat arterial blood pressure, arterial oxygen saturation, and heart rate (HR) were determined, and stroke volume (SV) was estimated from impedance cardiography calibrated with soluble-gas rebreathing. There were large inter-individual variabilities of HR, mean arterial pressure (MAP), and total peripheral resistance (TPR) at end-apnea (ea). However, for each individual HR ea , MAP ea , and TPR ea were highly correlated between air and oxygen (R=0.94, 0.78 and 0.93). HR decreased and MAP increased faster during apnea with air than with oxygen (ANOVA, p<0.05) but MAP ea was not different between conditions.
Introduction
Apnea occurs frequently in humans who suffer from obstructive sleep apnea (OSA) and among divers. Like diving animals, humans react with bradycardia and vasoconstriction during apnea (4; 18; 24) . Several factors induce or modify these cardiovascular responses, such as arterial hypoxia sensed by chemoreceptors, the accompanying hypercapnia, cessation of respiratory movements, and face immersion. The present study focuses on voluntary apnea without face immersion.
The role of hypoxemia has been investigated with varying results by others: Gross et al (8) showed in resting humans that the carotid chemoreceptors were essential for the bradycardic component of the response to apnea, so that subjects who had undergone bilateral carotid body resection instead had tachycardia during apnea. The hypertensive response to apnea, however, appeared not to be critically dependent on the intact carotid bodies, since it was similar to control. In contrast, Chen et al (5) , studying anesthetized pigs, found very little if any difference between the HR responses when apnea was induced with and without oxygen, but that arterial hypoxemia was essential to elicit the marked increase of systemic vascular resistance that they found during apnea with air. These results obtained in resting humans and animals are not necessarily relevant for the understanding of the physiology of the underwater swimmer, who is physically active and therefore has increased oxygen requirement and carbon dioxide production, heart rate (HR), cardiac output and systemic vascular conductance. Both the increased rate of O 2 consumption and the enhanced cardiac output will tend to speed up the rate at which arterial hypoxemia develops during apnea. Thus it is possible that hypoxemia will have a much larger relative importance for the cardiovascular responses during exercise conditions than at rest. To our knowledge only one study has previously addressed the question of the effects of oxygen and hypoxemia on apnea in exercising humans (19) and it employed only a modest work intensity and restricted the cardiovascular measurements to that of HR.
In the present study we have investigated humans performing moderately heavy exercise at a metabolic rate which should equal that of normal swimming (9) . We reasoned that in order to properly define the role of hypoxemia for cardiovascular responses to apnea it would be necessary to approach the same levels of arterial desaturation as are likely to occur during actual breath-hold diving activities. We hypothesized that other factors than hypoxemia, and probably the respiratory arrest per se would be the principal cause of bradycardia and hypertension during apnea. Furthermore we wanted to take advantage of the wide interindividual variability of the strength of the cardiovascular responses to apnea that is known to exist (16; 18) . Thus we wanted to correlate the strength of the cardiovascular responses to apnea obtained with and without hypoxemia. We reasoned that if these responses were not correlated, then the individual sensitivity to hypoxemia would be a unique and independent factor behind the cardiovascular responses to apnea. On the other hand, if there were a significant correlation between responses with and without hypoxemia, then hypoxemia could be considered merely a modifying factor superimposed on a more basic response to apnea as originally suggested by Song et al (26) based on studies of resting humans. A second objective of this study was to investigate the effect of hypoxemia on cardiac output (CO). We hypothesized that hypoxemia might influence cardiac performance, so that cardiac output might become even more reduced than HR during the apnea-induced bradycardia, or at least that stroke volume (SV) would not be increased as result of the prolonged diastolic intervals in the same period.
Material and methods
Subjects. Eleven healthy male volunteers were studied; another two subjects that volunteered were excluded due to their inability to hold their breath for 30 s during exercise.
Age, weight, and height ranged 18-32 yr, 68-96 kg, and 176-194 cm. Subjects were nonsmokers. The protocol was approved by the Ethics Committee at Karolinska Institutet.
Protocol. During a separate session, subjects were familiarized with the experiment and their maximal O 2 uptake was determined with an incremental cycle ergometer test.
During the subsequent session with apneas, subjects performed sitting upright dynamic leg exercise on an electrically braked cycle ergometer (Type 380 B, Siemens-Elema AB, Stockholm, Sweden) at 100 W for about 60 minutes. During this steady-state exercise period, subjects held their breath repeatedly at a standardized lung volume with their glottis closed; before apneas subjects exhaled to residual volume (RV) and then inspired 60% of their vital capacity from a bag that had been pre-filled with either a normoxic gas with 1.6% CHClF 2 (Freon 22, R22) and 5% helium in nitrogen, or 95% oxygen with 5% helium. For simplicity these two gas mixtures will be referred to below as air and oxygen respectively. Apneas were interrupted by the medical supervisor if oxygen saturation fell below 50%, or at the will of the subject. Shortly after the onset of exercise, subjects performed two test trials with short (10 s) apneas, and then performed alternating apneas with air and oxygen, three of each. In a pilot study we had determined that subjects always could detect whether air or oxygen was used, so randomization would not be meaningful. Subjects also performed two 15 s rebreathing maneuvers for determination of cardiac output (CO) from R22 uptake (3), one after the second apnea and the other after the fourth apnea using the air mixture. There was at least 5 min of eupnea between all apnea maneuvers, or more if the subject did not feel that he had recovered after the previous maneuver.
Measurements
The system used for gas supply and respiratory measurements has been described previously (32) . Briefly, the system allowed continuous measurements of respired gas flow and concentrations, and rebreathing with preset bag volumes. Gas analysis was performed with a quadrupole mass spectrometer (QMG 420, Balzer, Lichtenstein) modified for respiratory measurements (Innovision AS, Odense, Denmark). The gas analyzer was calibrated against mixtures of known concentrations (AGA Gas AB, Lidingö, Sweden). Vital capacity (VC) was determined for each subject when sitting on the cycle ergometer. The largest value out of 3 trials was adopted.
An electrocardiogram (ECG) was acquired from chest electrodes and a combined amplifier and beat-by-beat tachometer (Biotach ECG, mod 20-4615-65, Gould Inc., Valley View, OH).
Ear-lobe arterial oxygen saturation (SaO 2 ) was measured with a beat-by-beat pulse oximeter (Satlite trans, Datex Engstrom, Finland). The subject's earlobe was rubbed with an ointment containing capsaicin to enhance local blood flow (1) .
Blood pressure was measured with a photoplethysmographic finger-cuff method (Finapres 2300, Ohmeda, Englewood, CO).
Transthoracic impedance (TTI) was recorded from two pairs of tape electrodes around the neck and lower thorax (29) .
Data acquisition and analysis. All measurements were recorded with a computer-based data collection system (Biopac Systems Inc., Goleta, CA). Calibrated analog signals were A/D converted and recorded at 200 Hz per channel, and subsequently stored and analyzed with an AcqKnowledge 3.2.6 software package (Biopac Systems Inc., Goleta, CA).
During resting apnea, heart rate (HR) values were obtained as an average during the 10 s with the lowest HR. During exercise baseline data were obtained as time averages for 30 s periods 45-15 s before apneas started. HR and mean arterial pressure (MAP) during apneas were determined from beat-by-beat curves as time averages during 5 s intervals. Stroke volume (SV) was calculated from ten beats during baseline before apnea, and during the last ten beats of each apnea. SV was determined with a modification of the impedance method originally described by Kubicek et al (11) . Thus SV estimates were obtained from the maximal first derivative of the impedance signal together with ejection time, which was assessed from the contour of the second derivative of the blood pressure curve (25) . The impedance estimates of stroke volume were calibrated during steady-state exercise using simultaneous rebreathing measurements of cardiac output and impedance cardiography. The calibration factor obtained in this way for each individual was then used to calculate SV during apnea. Cardiac output (CO) was obtained as SV*HR, and total peripheral resistance (TPR) as MAP/CO. Below, variables from the ten last heart beats of apnea during exercise will be indexed with ea for end apnea, e.g. HR ea. Also, the terms apnea and end-apnea will refer to exercise conditions when not stated otherwise.
Statistics. Differences between conditions were analyzed using a paired Student´s t-test for dependent variables. Also, multiple regression analysis and ANOVA were used (Statistica, Statsoft, Tulsa, OK). Significance was accepted at the 5% level. Group mean responses at end-apnea are shown in Fig 3. MAP ea was not different between the two conditions, while SV ea remained at pre-apnea control level with air but increased significantly by 14+/-14% during apnea with oxygen. HR ea and CO ea were also higher during apneas with oxygen than with air. The HR and TPR responses to apnea during exercise varied widely among the subjects: The coefficient of variations for the differences from pre-apnea were 64% for TPR ea , 74% for HR ea , and 15% for MAP ea during apnea with air. The corresponding values with oxygen were 56, 81 and 24%. In order to further analyze individual differences in responses to apnea, we performed multiple correlations (Fig 4, 5 , Table 1 ). Subjects that reacted to apnea with a marked bradycardia did so under both conditions. Thus, HR ea values with oxygen were well correlated with corresponding values with air. Also for MAP ea and TPR ea there were significant correlations between values obtained with air and oxygen. Subjects with the lowest heart rate during apnea with air had the highest value of TPR ea (Fig 5) . The correlation between TPR ea and HR ea was not significant during apnea with oxygen. The hypertensive response during apnea as determined by MAP ea was not statistically correlated to HR ea (Table 1) , nor were changes in MAP significantly correlated to changes in HR during apnea. There were no significant correlations between O V .
Results

Mean apnea time was
2 max or relative work intensity on one hand and any of the cardiovascular response parameters during apnea on the other.
Group mean PCO 2 at the end of the longest apnea for each subject was 7.8 kPa (range 6.7-8.8 kPa) for apneas with air and 9.4 kPa (range 7.5-11.9 kPa) for oxygen (p=0.0004). In the air experiments there was no correlation between PCO 2 (end-tidal PCO 2 after apnea -endtidal PCO 2 before apnea) and apnea duration, but with oxygen, end-apneic PCO 2 was significantly correlated to apnea duration (Fig 6) . For both air and oxygen, we found no correlations between end-tidal PCO 2 after and HR ea and no correlation between apnea time and HR ea .
Discussion
Hypoxemia and cardiovascular responses to apnea Figure 2 clearly demonstrates that both with and without a progressive hypoxemia there was a gradual fall of HR and a gradual rise of MAP during apnea in exercising men.
Furthermore, cardiovascular responses to apnea developed faster during hypoxemic apnea than during hyperoxic apnea, and as apnea was continued for a longer period with hyperoxia, blood pressure continued to rise and HR continued to drop. Overall, therefore, our data obtained in exercising men demonstrate that there are at least 2 components of both the bradycardic and hypertensive responses to apnea: In the case of MAP, there is one major nonhypoxemic component and one quantitatively smaller component which is associated with gradually developing hypoxemia. For HR the two components appear to be of similar magnitudes. These findings could be interpreted against the background of a previous study comparing responses for similar degrees of hypoxemia in both apnea and rebreathing in exercising men (16): they found a marked bradycardia with apnea but not when the same progressive hypoxemia was induced by rebreathing, and concluded that respiratory arrest rather than the accompanying hypoxemia was essential for the bradycardic responses to apnea. Taken together, the present data and those of Lindholm et al (16) support the notion that there are specific bradycardic and hypertensive responses to hypoxemia but these will only be apparent if associated with respiratory arrest.
These conclusions contrast somewhat to the results of van den Aardweg and Karemaker (31) who showed that during resting apnea there was no hypertension without hypoxemia.
One tentative explanation for the difference between the present findings and those of van den Aardweg and Karemaker (31) could be that they studied apneas of 20 s duration, and since the hypertensive and bradycardic responses develops gradually, their observation time may have been too brief to reveal responses in the absence of hypoxemia, when these responses develop at a slower rate.
There is much evidence that hypoxemic components of the cardiovascular responses to apnea are mediated by arterial chemoreceptors (8; 22) . However, indirect cardiovascular effects of oxygenation must also be considered. Thus, hypercapnia has been shown to attenuate the bradycardic response to apnea (15) , and if the degree of hypercapnia was more severe with hyperoxic apnea, that might have contributed to the higher HR values for a given apnea duration. At a given CO 2 content, oxygenated blood will have a higher PCO 2 than deoxygenated blood due to the Haldane effect (10) . Consequently the higher end-apneic PCO 2 with oxygen may not only be a product of the 70 per cent longer apnea duration, but arterial PCO 2 might also have been higher with oxygen for a given apnea duration. In the present study it was not possible to determine end-tidal PCO 2 as a function of apnea duration within one subject. However, on a group basis, this relationship could be studied as shown in Figure   6 . These data suggest that there is no time-dependent increase of PCO 2 during apnea with air but that there was such an increase during apnea with oxygen. However, the range of apnea times differs greatly between the two conditions with a much smaller range with air, so the lack of time-dependent trend with air cannot be considered as conclusive. More conclusive evidence for a lack of time-dependent increase of PCO 2 during apnea with air can be found in a recent study by Lindholm and Linnarsson (17) . These authors studied apneas with air of 15, 24, 34, and 44 s durations in exercising men, and from 24 s and onwards there was no increase in post-apneic end-tidal PCO 2 . Taken together, data from the present study and those of Lindholm and Linnarsson (17) indicate that there is a time-dependent gradual increase of PCO 2 during apnea when arterial oxygen saturation is maintained because the subject inhaled oxygen before the apnea, but not when there is a gradually developing hypoxemia during apnea after inhaling air. We can therefore not exclude that part of the presently observed attenuation of apnea-induced bradycardia and hypertension with oxygen was an indirect effect of oxygen mediated through interaction with CO 2 transport in the blood and a resulting elevation of arterial PCO 2 .
In an attempt to further analyze the role of hypoxemia for the cardiovascular responses to apnea we studied the inter-individual variation of responses and how these correlated between experimental conditions. The inter-individual variation of the bradycardic responses were fairly large with coefficients of variation of 74 and 81 % for air and oxygen. At the same time there was a significant correlation between individual responses in the two conditions (Table   1 , Fig 4) . Similar variabilities and correlations were found for TPR and MAP (Table 1 , Fig 4) .
Thus subjects with the largest bradycardic, vasoconstrictive, and hypertensive responses with air also had the largest responses with oxygen. There was also a significant negative correlation between HR ea and TPR ea during apnea with air, showing that individuals with the largest chronotropic response also had the largest vasoconstrictive response. There was a similar non-significant trend at the end of apnea after oxygen inhalation. These findings support the notion that the strength of the cardiovascular response to apnea in a given individual is determined primarily by other mechanisms than the individual sensitivity to hypoxemia. Furthermore, the individual response pattern appears to be determined at the level of central cardiovascular control rather than at effector organ level since it includes both cardiac-chronotropic and vasoconstrictive responses.
It should be considered to what extent arterial baroreflexes play a role in the combined bradycardia and hypertension during apnea. If so, one would expect a significant negative correlation between MAP and HR so that subjects with the largest hypertensive response also would have the largest degree of bradycardia. This was, however, not the case (Table 1 ). The lack of correlation between MAP and HR responses is also illustrated in Figure 1 showing two individuals with similar hypertensive responses but with markedly different bradycardic responses. Further evidence against a baroreflex origin of the bradycardic response to apnea is to be found in the study of Lindholm et al (16) where apnea was compared with rebreathing:
Despite a significant hypertensive response to rebreathing, albeit less than during apnea, there was no bradycardic response. In addition, Sundblad et al (28) studied combined effects of apnea and baroreceptor stimulation by means of neck suction in exercising subjects, and concluded that there was an apnea-specific bradycardia far in excess of what could be accounted for by the hypertensive baroreceptor stimulus.
A study performed by Finley et al (6) lends further support to the notion that the bradycardic response to apnea is "preprogrammed" rather than baroreflex-induced. These authors studied subjects performing short-lasting apnea and face immersion during exercise at an intensity similar to that in the present study, and with various types of autonomic blockade.
During parasympathetic blockade with atropine the bradycardic response was abolished, confirming the previously established notion that an increase of vagal outflow is the final common pathway for the bradycardia during apnea. This does in itself not distinguish between a primary or a secondary baroreflex origin of the bradycardia, but Finley et al (6) also studied the effects of -blockade in these subjects. During -blockade the hypertensive response was abolished but the bradycardia was the same as during control. With reservations for the limited subject population of their study, and for the differing apnea procedure as compared to the present study, their results suggest that hypertension is not a necessary prerequisite for the apnea-associated bradycardia, which therefore primarily not is of baroreflex origin.
Cardiac output
Cardiac output is determined by a number of influences during apnea. Clearly, the hypertensive response during apnea leads to an increased afterload which will tend to reduce cardiac output. The increase of TPR during apnea will also decrease the rate at which the dependent deep muscle veins fill between muscle contractions (21) . Thus the apneaassociated increase of TPR will tend to decrease the efficiency of the muscle pump, and the associated reduction of venous return will also act to reduce cardiac output. At the same time, the associated bradycardia will prolong the time for diastolic filling, and thereby promote increased stroke volumes. The net effect on cardiac output and SV of combined increases of sympathetic and vagal outflow to the heart (6) is difficult to predict, because of the multiple levels of sympathovagal interaction (13) .
Subjects held their breath against a closed glottis and the diaphragmatic contractions during the late phase of the apnea were likely to have caused large intra-thoracic pressure swings with a mean pressure below zero as shown by Lin et al (14) . The possibility should be considered whether these repeated waves of negative intrathoracic pressure contributed to the hypertensive response by augmenting venous return to the right heart and thereby stroke volume. A closer inspection of the time course of the hypertensive response (Fig 1) , however, reveals that it peaks after the apnea period and when normal breathing is resumed, speaking against involuntary diaphragmatic movements during end-apnea as a factor behind the hypertension. Further evidence against this possibility has been shown in resting humans by Leuenberger et al (12) who showed that the leg peripheral resistance reached its peak and leg blood flow its nadir during the first 5 s of resumed breathing after apnea.
In the present experiments with oxygen CO ea was reduced by 11% and SV ea was increased by 14% compared to pre-apnea. This shows that the positive effects of prolonged diastolic filling and possibly also sympathetically-induced increase of contractility (6) (5) support the notion that the higher SV during apnea with oxygen also in the present study was caused by normalization of hypoxemia, with the caveat that, as described above, both species and important aspects of the experimental conditions were different.
As a consequence of the unchanged SV during apnea with air, compared with pre-apnea control, the apnea-induced changes of cardiac output during exercise and air breathing can be estimated fairly well from concomitant changes of heart rate.
Limitations of the study
An important limitation of this and all other human studies of non-steady-state hemodynamics is the absence of a direct method for beat-by-beat determination of stroke volume, and the associated values for cardiac output and total peripheral resistance. When right-heart catheterization is feasible, thermodilution would come closest to the ideal in terms of time resolution, and among the non-invasive methods, soluble-gas rebreathing is the most welldocumented alternative (30) but requires steady-state for the duration of a circulation time through the systemic circulation. For the purpose of the present study right-heart catheterization was not feasible, and rebreathing could not be employed since it has been shown to eliminate the bradycardic response to apnea (16) . The present compromise was to employ impedance cardiography as an index of stroke volume but with preceding individual calibration during eupnea. Fuller (7) in a meta-analysis of impedance cardiography concluded that there was a moderately good correlation with other techniques in healthy subjects, with rvalues ranging 0.80-0.83, when termodilution, dye dilution and direct Fick techniques were used as references. Important factors causing variability of impedance cardiography estimates when using standard algorithms are inter-individual differences in thoracic shape and interexperiment variability of electrode placement (20) . We attempted to circumvent these problems by comparing data from air and oxygen within one specific experimental session and by calibrating the impedance estimates with rebreathing within the same session, thereby avoiding standard algorithms and the associated assumptions of for example a standard thoracic geometry and a standard blood conductivity. Our findings during apnea with air are similar to those obtained by Bjertnaes et al (2) in two subjects using thermodilution. Moreover the air-oxygen cardiac output differences obtained at end-apnea in the present study agree well with corresponding animal data obtained by Chen et al (5) . In conclusion we feel confident that our non-invasive estimates of SV are at least sufficiently accurate to detect relative differences between the various conditions in the present study.
The relative work intensity during the apneas differed between subjects, which potentially may have increased the interindividual variability of responses. However, Strömme et al (27) and the present study found no correlation between cardiovascular response parameters to apnea and relative work intensity. Instead, by choosing constant submaximal work load and breath-hold volume above RV we standardized the ratios between O 2 need and pulmonary O 2 stores and thereby the rate of development of hypoxemia as far as possible.
This and earlier studies of apnea during dynamic leg exercise (16; 17) have shown that it takes about 20 sec of apnea before significant cardiovascular responses can be observed. By definition, then, such responses can only be observed in volunteers that can tolerate apnea during exercise for longer than that, in our case 30 seconds. We cannot be sure, therefore, that the presently observed cardiovascular responses are typical of a larger population. However, the great variability of responses, e.g. bradycardic responses ranging from almost none to profound speak against the notion that our subject selection criteria biased the outcome of the study.
Conclusions and perspectives
When the data of the present study are put together with previous studies of apnea in exercising men (2; 16; 17) the following over-all picture emerges: First, the cardiovascular responses to apnea in exercising humans clearly delay the development of hypoxemia (16) by reducing the rate of uptake from the main oxygen store, i.e. the lungs (17) . Second the respiratory arrest per se is instrumental in eliciting the cardiovascular responses; neither the associated hypercapnia or hypoxemia elicit bradycardia when occurring without respiratory arrest (16) . Third, hypoxemia when occurring with respiratory arrest appears to provide an additional stimulus for bradycardia and to some extent hypertension. Fourth the hypoxemia influences the heart directly or indirectly so that there is no increase in stroke volume despite a marked bradycardia-related increase of diastolic filling time. Finally, the cardiovascular responses to apnea and the associated protective effect against hypoxemia is highly variable among individuals, rendering some individuals more fit for breath-hold diving than others. Original recordings from two subjects, showing (from top) earlobe arterial oxygen saturation (SaO 2 ), heart rate (HR), mean arterial pressure (MAP) and respiratory flow rate as functions of time. Recordings show apneas with air (first apnea) and oxygen (second apnea) in both subjects. Inspired lung volumes before apnea in these subjects were 3.5 l for A and 3.4 l for B.
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Note the difference between HR responses of the two individuals. Respiratory flow data are missing between maneuvers since subjects temporarily remove the mouthpiece. Correlations of HR, MAP and total peripheral resistance (TPR) at end-apnea with oxygen vs.
corresponding data obtained with air. Data from 11 subjects, each data point represents the average of 2-3 repetitions in each subject and condition. There were significant correlations between data obtained with air and oxygen for all three variables, see Table 1 . See also Fig 1 for explanation of symbols. 
